Kimberly H. Allison

Active 2004–2025

79
Papers
27,339
Citations
55
h-index
78
i10-index

Citations

Citations per year for Kimberly H. Allison1995: 1 citations1999: 1 citations2003: 1 citations2005: 1 citations2007: 4 citations2008: 6 citations2009: 19 citations2010: 13 citations2011: 28 citations2012: 50 citations2013: 39 citations2014: 67 citations2015: 116 citations2016: 209 citations2017: 271 citations2018: 266 citations2019: 837 citations2020: 1,120 citations2021: 1,223 citations2022: 953 citations2023: 820 citations2024: 1,311 citations2025: 604 citations2026: 46 citations1996–1998: no citations, so these years are not shown2000–2002: no citations, so these years are not shown2004: no citations, so this year is not shown2006: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,695 citing papers, 22.5% of this breakdownChina: 1,448 citing papers, 12.1% of this breakdownItaly: 688 citing papers, 5.7% of this breakdownUnited Kingdom: 597 citing papers, 5% of this breakdownGermany: 477 citing papers, 4% of this breakdownFrance: 437 citing papers, 3.6% of this breakdownCanada: 382 citing papers, 3.2% of this breakdownSpain: 365 citing papers, 3% of this breakdownAustralia: 354 citing papers, 3% of this breakdownJapan: 347 citing papers, 2.9% of this breakdownSouth Korea: 345 citing papers, 2.9% of this breakdownBelgium: 306 citing papers, 2.5% of this breakdown
0%22.5%Other 29.6%

Fields

  • Medicine51.2%
  • Biochemistry, Genetics and Molecular Biology31.8%
  • Computer Science9%
  • Immunology and Microbiology3.3%
  • Engineering2%
  • Materials Science0.6%
  • Other2.1%

Topics

  • Breast Cancer Treatment Studies8%
  • Cancer Immunotherapy and Biomarkers6.4%
  • HER2/EGFR in Cancer Research4.9%
  • AI in cancer detection3.9%
  • Cancer Cells and Metastasis3.3%
  • Radiomics and Machine Learning in Medical Imaging3.1%
  • Other70.4%

Coauthors

All papers

Open in search
  1. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen Willard‐Gallo, Sherene Loi - Annals of Oncology 2014 cited by 3,136

  2. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 1,497

  3. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Kari B. Wisinski, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2022 cited by 964

  4. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update

    Authors: , , , , , , , , - Journal of Clinical Oncology 2023 cited by 581

  5. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

    Authors: , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2018 cited by 2,454

  6. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tari A. King, Charles M. Perou, Rehan Akbani, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Thomas Barr, Andrew H. Beck, Christopher C. Benz, Stephen C. Benz, Mario Berríos, Rameen Beroukhim, Tom Bodenheimer, Lori Boice, Lori Boice, Jay Bowen, Reanne Bowlby, Denise Brooks, Andrew D. Cherniack, Lynda Chin, Juok Cho, Sudha Chudamani, Giovanni Ciriello, Tanja M. Davidsen, John A. Demchok, Jennifer B. Dennison, Li Ding, Ina Felau, Martin L. Ferguson, Scott Frazer, Stacey Gabriel, Jianjiong Gao, Julie M. Gastier-Foster, Michael L. Gatza, Nils Gehlenborg, Mark Gerken, Gad Getz, William J. Gibson, D. Neil Hayes, David I. Heiman, Katherine A. Hoadley, Andrea Holbrook, Robert A. Holt, Alan P. Hoyle, Hai Hu, Mei Huang, Carolyn M. Hutter, E. Shelley Hwang, E. Shelley Hwang, Steven J.M. Jones, Zhenlin Ju, Jaegil Kim, Phillip H. Lai, Peter W. Laird, Michael S. Lawrence, Kristen M. Leraas, Tara M. Lichtenberg, Pei Lin, Shiyun Ling, Jia Liu, Wenbin Liu, Laxmi Lolla, Yiling Lu, Yussanne Ma, Dennis T. Maglinte, Elaine R. Mardis, Jeffrey R. Marks, Marco A. Marra, Cynthia McAllister, Michael D. McLellan and 60 more - Cell 2015 cited by 1,981

  7. NCCN Guidelines® Insights: Breast Cancer, Version 4.2023

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melinda L. Telli, Mei Wei, Kari B. Wisinski, Jessica Young, Kay T. Yeung, Mary A. Dwyer, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2023 cited by 440

  8. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melinda L. Telli, John H. Ward, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2020 cited by 1,618

  9. The 2019 World Health Organization classification of tumours of the breast

    Authors: , , , , , , , , , , , , , , , , , , - Histopathology 2020 cited by 1,074

  10. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 799

  11. Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium

    Authors: , , , , , , - Nature Materials 2014 cited by 840

  12. Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens

    Authors: , , , , , , , , , , , - JAMA 2015 cited by 723

  13. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, Mei Wei, Kari B. Wisinski, Kay T. Yeung, Jessica Young, Ryan Schonfeld, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2024 cited by 560

  14. Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 347

  15. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 720

  16. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2013 cited by 4,061

  17. Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2020 cited by 369

  18. Molecular analysis of TCGA breast cancer histologic types

    Authors: , , , , , , , , , , , - Cell Genomics 2021 cited by 116

  19. NCCN Guidelines® Insights: Breast Cancer, Version 4.2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Kari B. Wisinski, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2021 cited by 351

  20. HER2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Summary

    Authors: , , , , , - Journal of Oncology Practice 2018 cited by 183

  21. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carlos Castaneda, Marleen Kok, Heather L. McArthur, Kalliopi P. Siziopikou, Sunil Badve, Susan Fineberg, Allen M. Gown, Giuseppe Viale, Stuart J. Schnitt, Giancarlo Pruneri, Frederique Penault‐Llorca, Stephen M. Hewitt, E. Aubrey Thompson, Kimberly H. Allison, W. Fraser Symmans, Andrew M. Bellizzi, Edi Brogi, David A. Moore, Denis Larsimont, Deborah Dillon, Alexander J. Lazar, Huang‐Chun Lien, Matthew P. Goetz, Glenn Broeckx, Khalid El Bairi, Nadia Harbeck, Ashley Cimino‐Mathews, Christos Sotiriou, Sylvia Adams, S Liu, Sibylle Loibl, I‐Chun Chen, Sunil R. Lakhani, Jonathan Juco, Carsten Denkert, Elizabeth F. Blackley, Sandra Demaria, Roberto A. Leon‐Ferre, Oleg Gluz, Dimitrios Zardavas, Kenneth Emancipator, Scott Ely, Sherene Loi, Roberto Salgado, Melinda E. Sanders, International Immuno‐Oncology Biomarker Working Group - The Journal of Pathology 2020 cited by 226

  22. Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues

    Authors: , , , , , , , , , , , , , , - Clinical Chemistry 2021 cited by 47

  23. Updates on breast biomarkers

    Authors: , - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2022 cited by 70

  24. Incidence of endometrial hyperplasia

    Authors: , , , , , , , - American Journal of Obstetrics and Gynecology 2009 cited by 219